The largest database of trusted experimental protocols

Ultrapure lps from e coli o111 b4

Manufactured by InvivoGen
Sourced in United States

Ultrapure LPS (from E. coli O111:B4) is a laboratory product that provides a highly purified form of lipopolysaccharide (LPS) derived from the E. coli O111:B4 strain. LPS is a major component of the outer membrane of Gram-negative bacteria and is commonly used in research applications.

Automatically generated - may contain errors

7 protocols using ultrapure lps from e coli o111 b4

1

Evaluating iNKT Cell Activation and Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For BrdU labeling, mice were injected I.P. with 1 mg BrdU daily for six days. One day later, tissues were harvested and BrdU incorporation in iNKT cells was evaluated with the BrdU Flow Kit (BD Pharmingen) per the manufacturer’s instructions. As a cytokine-driven model of iNKT cell activation, mice were injected I.V. with 2mg ultra-pure LPS from E. coli O111:B4 (InvivoGen) per kg body weight. As an antigen-driven model of iNKT cell activation, mice were injected I.P. with 1 μg αGalCer analog KRN7000 (Avanti Polar Lipids). Both αGalCer and LPS were prepared in DMSO and diluted 1:10 (v/v) in sterile saline immediately prior to injection. Mice were sacrificed and tissues harvested after either 4 or 72 hours. In some experiments, mice were injected I.P. with 200μg ultra-low endotoxin azide-free anti-IFNγ (XMG1.2) or isotype control antibodies (Biolegend) 8 hours prior to αGalCer injection. For in vivo analysis of apoptosis mice were injected I.V. with the fluorescent poly-caspase binding reagent FAM-FLIVO (Immunochemistry Technologies) and analyzed per the manufacturer’s instructions. For ex-vivo intracellular cytokine staining, suspensions of SVF cells were cultured for two hours at 37°C in complete media in the presence of Brefeldin A prior to staining with flow cytometry antibodies.
+ Open protocol
+ Expand
2

Lipopolysaccharide-Induced Kidney and Spleen Response

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight-week-old male C57BL/6 mice were i.p. administered either 200 μg of lipopolysaccharide (Ultrapure LPS; 1 mg/ml in sterile LPS-free phosphate-buffered saline, n = 6) in a total volume of 200 μl or an equal volume of sterile LPS-free phosphate-buffered saline (n = 6) (Ultrapure LPS from E. coli O111:B4, InvivoGen, Toulouse, France). Urine samples were collected and analyzed 24 hours post injection and immediately prior to sacrifice. Kidneys and spleens were then removed for morphological and protein studies.
+ Open protocol
+ Expand
3

HDM Sensitization and Challenge Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For preparation of HDM immunizations, whole crushed D. pteronyssinus HDM powder (Greer Laboratories Inc.) was resuspended in sterile PBS. For experiments that performed allergic sensitization and challenge, mice were anesthetized with isofluorane and administered HDM via the oropharynx at a concentration containing 23 μg Der p 1 protein in a volume of 40 μl during the primary sensitization. Beginning at 10 d after sensitization, mice were anesthetized with isofluorane and instilled with HDM in the oropharynx at a concentration containing 5.75 μg Der p 1 protein daily for 5 d during the allergic challenge phase.
For acute respiratory challenge experiments with HDM, papain, LPS, and recombinant cytokines, mice were anesthetized with isofluorane and administered the target molecules in a total volume of 40 μl diluted in sterile PBS via the oropharynx for the indicated days. On each day, mice were given HDM normalized to 5.75 μg Der p 1 protein (Greer Laboratories Inc.), 25 μg papain (from papaya latex, aseptically filled; Sigma-Aldrich), 10 μg Ultrapure LPS from E. coli O111:B4 (InvivoGen), 50 ng recombinant mouse IL-33 (BioLegend), and/or 500 ng recombinant mouse IL-18 (BioLegend) as described in the relevant figures.
+ Open protocol
+ Expand
4

Neutrophil Oxidative Burst Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ly6G+ CD11b+ cells in bone marrow were sorted as neutrophils using FACSAriaIII. Purified neutrophils were stimulated in the presence or absence of 100 ng/ml Ultra-pure LPS from E. coli O111:B4 (InvivoGen, San Diego, CA) or 10 ng/ml granulocyte-macrophage colony-stimulating factor (GM-CSF) (Kirin Brewery, Gunma, Japan) for 6 h, and then incubated with 10 μM of dihydrorhodamine-123 (DHR-123) (Sigma–Aldrich) for 30 min in quadruple cultures. Fluorescence intensity was determined using FACSCalibur. Results were calculated according to the following formula: rhodamin-123 fluorescence = mean fluorescence intensity (MFI) of stimulated cells/MFI of unstimulated cells × 100.
+ Open protocol
+ Expand
5

Immune Response Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Synthetic M-triDAP, ultrapure LPS from E.coli O111:B4 and synthetic polyriboinosinic:polyribocytidilic acid (poly-I:C) were from In vivogen (San Diego, CA). LPS was confirmed to be free of NOD1/NOD2 agonists using a test system described earlier (29 (link)). All agonists were dissolved in endotoxin-free water (In vivogen). Complexes of poly-I:C with Lipofectamine 3000 (lipo-poly-I:C) were prepared as recommended by the manufacturer of Lipofectamine (Thermo Fisher Scientific, Waltham, MA). Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) was from Miltenyi Biotec (Bergisch Gladbach, Germany), and recombinant human interferon-beta (rhIFN-β1b) from Generium (Moscow, Russia). Complete culture medium (CCM) was RPMI-1640 supplemented with 2-mM L-glutamine and 10% fetal calf serum (all from Thermo Fisher Scientific). IκB kinase β inhibitor (PF-184) was from Tocris (Bristol, UK), actinomycin D (ActD) from Sigma (St-Louis, MO).
+ Open protocol
+ Expand
6

Apoptosis and Pyroptosis Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used: anti-Caspase-1 (D7F10 from Cell Signaling Technology, Danvers, MA, USA), anti-Caspase-4 (4450 from Cell Signaling Technology, Danvers, MA, USA), anti-Caspase-5 (D3G4W from Cell Signaling Technology, Danvers, MA, USA); anti-actin (C4 from MP Biomedicals); anti-GSDMD (G7422 from Sigma-Aldrich, St. Louis, MO, USA), anti-GSDMD N-term (E7H9G from Cell Signaling Technology, Danvers, MA, USA), anti-IL-1β (MAB601, R&D Systems, Inc., Minneapolis, MN, USA). All cell culture media reagents were purchased from Thermo Fisher (Waltham, MA, USA). Ultrapure LPS (from E. coli O111:B4) was purchased from Invivogen (San Diego, CA, USA). Unless otherwise indicated, all other reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand
7

Inflammasome Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used: anti-Caspase-1 (D7F10 from Cell Signaling Technology, Danvers, MA, USA), anti-Caspase-4 (4450 from Cell Signaling Technology, Danvers, MA, USA), anti-Caspase-5 (D3G4W from Cell Signaling Technology, Danvers, MA, USA); anti-actin (C4 from MP Biomedicals); anti-GSDMD (G7422 from Sigma-Aldrich, St. Louis, MO, USA), anti-GSDMD N-term (E7H9G from Cell Signaling Technology, Danvers, MA, USA), anti-IL-1β (MAB601, R&D Systems, Inc., Minneapolis, MN, USA), anti-IL-1β cleaved, Asp116 (PA5-105048 from Thermo Fisher, Waltham, MA, USA). All cell culture media reagents were purchased from Thermo Fisher (Waltham, MA, USA). Ultrapure LPS (from E. coli O111:B4) was purchased from Invivogen (San Diego, CA, USA). Unless otherwise indicated, all other reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!